ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,473.17
      -0.25%
      US Tech 100
      19,288.80
      -0.62%
      Dow Jones
      39,134.76
      0.77%
      Brent Oil
      84.965
      -0.05%
      Bitcoin
      64,594.37
      -0.35%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cogent Biosciences Inc (COGT)

      7. Cogent Biosciences Inc (COGT) Financials

      Cogent Biosciences Inc

      Cogent Biosciences Inc (COGT)

      NASDAQ
      8.36
      -0.14
      (-1.65%)
      Closed June 21 4:00PM
      Delayed by 15 minutes
      8.36
      0.00
      (0.00%)
      After Hours: 4:06PM
      Delayed by 15 minutes

      Cogent Biosciences Inc Financial Summary

      The current COGT market cap is 868.72M. The company's latest EPS is USD -1.8516 and P/E is -1.27.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -43.24M-47.09M-59.58M-58.23M-62.4M
      Net Income -38.59M-44.08M-55.38M-54.37M-58.35M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 22.5M7.87M000
      Operating Income -32.18M-82.2M-75.55M-147.84M-208.13M
      Net Income -31.83M-74.81M-72.27M-140.24M-192.41M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 263.2M392.37M355.45M313.44M476.11M
      Total Liabilities 39.64M43.94M52.55M55.64M53.78M
      Total Equity 223.56M348.43M302.9M257.8M422.33M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 49.42M250.92M232.09M300.81M313.44M
      Total Liabilities 17.66M16.25M17.91M45.08M55.64M
      Total Equity 31.76M234.67M214.18M255.74M257.8M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -39.52M-71.58M-109.55M-153.62M-52.53M
      Investing 59.88M-17.78M-108.31M-97.82M1.04M
      Financing 445k162.54M163.54M163.54M214.06M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -41.51M-35.85M-58.76M-118.64M-153.62M
      Investing 23.16M8.42M-1.72M-124.72M-97.82M
      Financing 108k232.2M37.98M163.56M163.54M

      Stats and Ratios

      Market Cap 868.72M
      Price to Earnings Ratio -1.27
      Price to Sales Ratio 0
      Price to Cash Ratio 4.59
      Price to Book Ratio 0.95
      Dividend Yield -

      Share Statistics

      Shares Outstanding 103.91M
      Average Volume (1 week) 995.37k
      Average Volume (1 Month) 1.38M
      52 Week Change -31.31%
      52 Week High 13.36
      52 Week Low 3.67
      Spread (Intraday) 0.76 (8.47%)

      Company Info

      Company Name Cogent Biosciences Inc
      Address 838 walker road
      dover, delaware 19904
      Website https://www.unumrx.com
      Industry pharmaceutical preparations (2834)